Mousavifar, L.; Sarshar, M.; Bridot, C.; Scribano, D.; Ambrosi, C.; Palamara, A.T.; Vergoten, G.; Roubinet, B.; Landemarre, L.; Bouckaert, J.;
et al. Insightful Improvement in the Design of Potent Uropathogenic E. coli FimH Antagonists. Pharmaceutics 2023, 15, 527.
https://doi.org/10.3390/pharmaceutics15020527
AMA Style
Mousavifar L, Sarshar M, Bridot C, Scribano D, Ambrosi C, Palamara AT, Vergoten G, Roubinet B, Landemarre L, Bouckaert J,
et al. Insightful Improvement in the Design of Potent Uropathogenic E. coli FimH Antagonists. Pharmaceutics. 2023; 15(2):527.
https://doi.org/10.3390/pharmaceutics15020527
Chicago/Turabian Style
Mousavifar, Leila, Meysam Sarshar, Clarisse Bridot, Daniela Scribano, Cecilia Ambrosi, Anna Teresa Palamara, Gérard Vergoten, Benoît Roubinet, Ludovic Landemarre, Julie Bouckaert,
and et al. 2023. "Insightful Improvement in the Design of Potent Uropathogenic E. coli FimH Antagonists" Pharmaceutics 15, no. 2: 527.
https://doi.org/10.3390/pharmaceutics15020527
APA Style
Mousavifar, L., Sarshar, M., Bridot, C., Scribano, D., Ambrosi, C., Palamara, A. T., Vergoten, G., Roubinet, B., Landemarre, L., Bouckaert, J., & Roy, R.
(2023). Insightful Improvement in the Design of Potent Uropathogenic E. coli FimH Antagonists. Pharmaceutics, 15(2), 527.
https://doi.org/10.3390/pharmaceutics15020527